TrialEuropean journal of nuclear medicine and molecular imaging2017

A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial.

Joyce M van Dodewaard-de Jong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.